Potentiation of the immune response in HIV-1+ individuals

Journal of Clinical Investigation

Volumn 97, Issue 6, 1996, Pages 1545-1549

  Schmitz, Tracy ^a   Underwood, Robert ^a   Khiroya, Raman ^a   Bachovchin, William W ^a   Huber, Brigitte T ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD26; DP IV; immunosuppression; immunotherapy; serine protease

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; SERINE PROTEINASE; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ANTIGEN BINDING; ARTICLE; CANDIDIASIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOTHERAPY; MEMORY CELL; MONONUCLEAR CELL; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0029984539     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118577     Document Type: Article

References (28)

1. Lane, C., J. Depper, W. Greene, G. Whalen, T. Waldmann, and A. Fauci. 1985. Qualitative analysis of immune function in patients with the acquired immuno-deficiency syndrome: evidence for a selective defect in soluble antigen recognition. N. Engl. J. Med. 313:79-81.
2. Viscidi, R.P., K. Mayur, H.M. Lederman, and A.D. Frankel 1989. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science (Wash DC). 246:1606-1608.
3. Gutheil, W.G., M. Subramanyam, G.R. Flentke, D.G. Sanford, E. Munoz, B.T. Huber, and W.W. Bachovchin. 1994 Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26). a possible mechanism for Tat's immunosuppressive activity. Proc. Natl. Acad. Sci. USA. 91:6594-6598.
4. Dang, N.H., Y. Torimoto, K. Deusch, S.F Schlossman, and C. Morimoto 1990. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways J. Immunol. 144:4092-4100
5. Subramanyam, M., W.G. Gutheil, W.W. Bachovchin, and B.T. Huber. 1993. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J Immunol 150:2544-2553.
6. Gossrau, R. 1985. Cytochemistry of membrane proteases. Histochem. J. 17:737-771.
7. Svensson, B , M Danielsen, M. Staun, L. Jeppesen, O. Noren, and H Sjostrom. 1978. An amphiphilic form of dipeptidyl peptidase IV from pig small-intestinal brush-border membrane. Purification by immunoadsorbent chromatography and some properties. Eur. J Biochem 90:489-498.
8. Puschel, G., R. Mentlein, and E. Heymann. 1982. Isolation and characterization of dipeptidyl peptidase IV from human placenta Eur J. Biochem 126: 359-365.
9. Fox, D.A., R.E. Hussey, K.A Fitzgerald, O. Acuto, C. Poole, L. Palley, J.F. Daley, S F. Schlossman, and E.L. Reinherz, 1984. Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J Immunol 133:1250-1256.
10. Yaron, A., and F Naider. 1993. Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol 28. 31-81.
11. Flentke, G.K., E. Munoz, B.T. Huber, A G. Plaut, C.A. Kettner, and W.W. Bachovchin. 1991 Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function Proc. Natl. Acad. Sci. USA. 88:1556-1559.
12. Wolf, B., G. Fischer, and A. Barth. 1978. Kinetics of dipeptidyl-peptidase IV. Acta Biol. Med. Ger 37:409-420.
13. Tanaka, T., J.S. Duke-Dohan, J. Kameoka, A. Yaron, L.I., S.F. Schlossman, and C Morimoto. 1994. Enhancement of antigen-induced T cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc. Natl. Acad. Sci. USA 91: 3082-3086.
14. Kubota, T , G.R. Flentke, W.W. Bachovchin, and B.D. Stollar. 1992 Involvement of dipeptidyl peptidase IV in an in vivo immune response Clin. Exp Immunol. 89:192-197.
15. + cells in peripheral blood and thyroid tissue of patients with Graves Disease. J. Immunol. 142:4233-4240.
16. Hafler, D., D. Fox, M. Manning, S.F. Schlossman, E. Reinherz, and H Weiner. 1985. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl. J Med. 312.1405-1411.
17. Muscat, C., A. Bertotto, E. Agea, O. Bistoni, R. Ercolani, R. Tognellini, F. Spinozzi, M. Cesarotti, and R. Gerli. 1994. Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cell in rheumatoid arthritis patients. Clin Exp Immunol. 98:252-256.
18. Blazquez, M.V., J A. Madueno, R. Gonzalez, R. Jurado, W.W. Bachovchin, J. Pena, and E. Munoz. 1992. Selective decrease of CD26 expression in T cells from HIV-1-infected individuals J. Immunol. 149:3073-3077.
19. + T lymphocytes of HIV-infected subjects. J. Acq. Immune Defic. Synd 6: 749-757
20. Helland, D.E., J L. Welles, A. Caputo, and W.A. Haseltine. 1991. Transcellular transactivation by the human immunodeficiency virus type 1 tat protein. J. Virol 65.4547-4549.
21. Ensoli, B., L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R A. Morgan, P. Wingfield, and R.C. Gallo 1993. Release, Uptake, and Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein on Cell Growth and Viral Transactivation. J Virol 67:277-287.
22. Chirmule, N., S. Than, S.A. Khan, and S. Pahwa. 1995. Human Immunodeficiency Virus Tat induces functional unresponsiveness in T cells. J. Virol. 69. 492-498.
23. Li, C.J., D.J. Friedman, C. Wang, V. Metelev, and A.B. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science (Wash. DC). 268:429-431.
24. Westendorp, M.O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K.-M Debatin, and P.H. Krammei. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature (Lond.) 375:497-500.
25. - T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331-340.
26. + donors by cysteine protease inhibitors. J. Immunol. 6:862-872.
27. Yang, Y., M. Vacchio, and J D. Ashwell. 1993. 9-cis Retinoic acid inhibits activation-driven T-cell apoptosis: implications for retinoid X receptor involvement in thymocyte development. Proc. Natl. Acad. Sci. USA 90:6170-6174.
28. Yang, Y., J. Bailey, M.S. Vacchio, R. Yarchoan, and J.D. Ashwell. 1995. Retinoic acid inhibition of ex vivo human immunodeficiency virus-associated apoptosis of peripheral blood cells. Proc. Natl. Acad. Sci. USA. 92.3051-3055.